- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
World Association of Sarcoidosis and Other Granulomatous Disorders, 2026 The post Evaluating Efzofitimod in a Subset of Sarcoidosis with the Restrictive Phenotype appeared first on aTyr Pharma.
Extracellular Matrix Pharmacology Congress, 2026 The post Natural Asp-tRNA Synthetase Fragment Interacts with LTBP-1 on the ECM Promoting Myofibroblast Apoptosis and Reducing Fibrosis appeared first on aTyr Pharma.
Brandon Yaras has served as our Vice President, Finance since May 2022. Mr. Yaras has nearly 20 years of corporate finance and accounting experience, having overseen internal and external SEC reporting, forecasting and valuation, SOX compliance, payroll and equity administration and accounts payable. Prior to joining aTyr, from 2014 to 2022, he served as Director […] The post Brandon Yaras appeared first on aTyr Pharma.
Journal of Biological Chemistry (2025) The post A Bispecific Antibody Designed to Act as a NRP2/PLXNA1 Agonist Mimics Anticancer Activity of SEMA3F appeared first on aTyr Pharma.
Keystone Symposia on Fibrosis: Cross Organ Pathology and Pathways to Clinical Development, 2026 The post Subcutaneous Delivery of a Natural Asp-tRNA Synthetase Fragment Targeting Myofibroblasts Shows Strong Exposure and Reduced Markers of Lung Inflammation appeared first on aTyr Pharma.
Darin Lee, Ph.D., has served as our Vice President, Technical Operations since November 2025. Dr. Lee has served in scientific and leadership roles at aTyr since joining the company in August 2011, including most recently as Sr. Director, Process Sciences. Dr. Lee has over 20 years of biopharmaceutical industry experience, with the majority focused on […] The post Darin Lee, Ph.D. appeared first on aTyr Pharma.
Federation of European Biochemical Societies: Expanding Frontiers in Aminoacyl-tRNA Synthetase Research, 2025 The post Advancing a Therapeutic Platform Based on tRNA Synthetases for Treatment of Fibrotic Lung Diseases appeared first on aTyr Pharma.
European Respiratory Society, 2025 The post EFZO-FIT™: The Largest Ever Interventional Trial in Pulmonary Sarcoidosis appeared first on aTyr Pharma.
American Thoracic Society, 2025 The post Incidence, Prevalence, and Mortality of Pulmonary Sarcoidosis with Parenchymal Involvement in the US appeared first on aTyr Pharma.
American Thoracic Society, 2025 The post EFZO-FIT™, the Largest Placebo-Controlled Trial in Pulmonary Sarcoidosis appeared first on aTyr Pharma.